Norovirus GII.17 accounted for < 10% of outbreaks in the US 2022-23 season, but rose to 75% during the 2024-25 season, passing the number of GII.4 outbreaks.

Will the upcoming norovirus season be just as early and active as the past year? While the answer may be anyone’s guess right now, federal health officials recently warned that the dominant ...

In previous years, the U.S. saw norovirus outbreaks increase around December, which marked the start of the season of the virus. Between 2011 and 2024, GII.4 viruses caused less than 50% of US ...

Increase in outbreaks of norovirus GII.17 over GII.4, United States, 2022–2025. Seasons are defined as September 1 of one year to August 31 of the next.

What You Need To Know A multistate norovirus outbreak has been linked to raw oysters from Texas, the Centers for Disease Control and Prevention announced The CDC said as of Thursday, 211 illnesses ...

A masked thief targeted a Pasadena coffee shop, smashing through a window and walking away with the store's cash register -- and the whole thing was caught on camera.

A gated Pasadena home that sprang up in the final days of the original Busch Gardens is on the market for $3.9 million. Built in 1936 and updated in 2019, this 4,174-square-foot English Revival ...

Here’s why Pasadena’s City Council said a former school campus can’t be a ‘landmark’ Housing advocates and district officials pushed for denial of landmark status to make a proposed ...

But it’s worth it. I wanted to share with you, as a neighbor, that our whole community is really involved in this quest to conquer norovirus.

A Pasadena man was sentenced to prison for the sexual assault of children across the U.S. Alvaro Maldonado Deza, 40, was sentenced to 23 years to life in state prison, the Pasadena Police ...

HOUSTON, Texas (KTRK) -- A Pasadena father will spend decades behind bars for the murder of his 2-year-old daughter. Court records show Jyron Charles Lee pleaded guilty to the 2022 murder of Nadia ...

Vaxart, Inc., a biotechnology company focused on oral recombinant pill vaccines, announced it will release topline data from its Phase I trial on norovirus before the market opens on June 11, 2025.